{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:04:47Z","timestamp":1790204687408,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010139","name":"Lahore University of Management Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010322","name":"Pakistan Academy of Sciences","doi-asserted-by":"publisher","award":["No.5-9\/PAS\/261"],"award-info":[{"award-number":["No.5-9\/PAS\/261"]}],"id":[{"id":"10.13039\/501100010322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.xphs.2022.01.001","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T20:56:02Z","timestamp":1641502562000},"page":"1509-1521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Nanoparticles as a Novel Tool to Inhibit Inflammatory Cytokines in Human Lymphocytes and Macrophages of Coronary Artery Disease"],"prefix":"10.1016","volume":"111","author":[{"given":"Rabia","family":"Shabbir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4414-1070","authenticated-orcid":false,"given":"Abida","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6410-6953","authenticated-orcid":false,"given":"Afrose","family":"Liaquat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed Ullah","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayyaz","family":"Chudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3834-6061","authenticated-orcid":false,"given":"Zajif","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.M.","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2022.01.001_bib0001","series-title":"2020 WHO cardiovascular disease","author":"Organization","year":"2021"},{"issue":"9","key":"10.1016\/j.xphs.2022.01.001_bib0002","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3390\/ijms17091534","article-title":"Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches","volume":"17","author":"Zhang","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2022.01.001_bib0003","first-page":"15","article-title":"Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants","volume":"7","author":"Sayols-Baixeras","year":"2014","journal-title":"Appl Clinic Genet"},{"key":"10.1016\/j.xphs.2022.01.001_bib0004","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.biopha.2018.11.116","article-title":"Anti-inflammatory mechanism of various metal and metal oxide nanoparticles synthesized using plant extracts: a review","volume":"109","author":"Agarwal","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"32","key":"10.1016\/j.xphs.2022.01.001_bib0005","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011685","article-title":"Impact of right coronary dominance on triple-vessel coronary artery disease: a cross-sectional study","volume":"97","author":"Peng","year":"2018","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.xphs.2022.01.001_bib0006","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/039463200702000117","article-title":"Inflammation and atherosclerosis: the role of TNF and TNF receptors polymorphisms in coronary artery disease","volume":"20","author":"Sbarsi","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.xphs.2022.01.001_bib0007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biomaterials.2015.12.022","article-title":"Knockdown of TNF-\u03b1 by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction","volume":"83","author":"Somasuntharam","year":"2016","journal-title":"Biomaterials"},{"issue":"23","key":"10.1016\/j.xphs.2022.01.001_bib0008","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.xphs.2022.01.001_bib0009","first-page":"1358","article-title":"The role of cytokines in the development of atherosclerosis","volume":"81","author":"Fatkhullina","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.xphs.2022.01.001_bib0010","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/S1071-9164(96)80073-X","article-title":"The effect of tumor necrosis factor-alphaon cardiac structure and function: a tale of two cytokines","volume":"2","author":"Mann","year":"1996","journal-title":"J Card Fail"},{"key":"10.1016\/j.xphs.2022.01.001_bib0011","first-page":"39","article-title":"Immune modulation of cardiac cell function","volume":"109","author":"Schreiner","year":"1998","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"1","key":"10.1016\/j.xphs.2022.01.001_bib0012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0147-9563(98)90063-2","article-title":"The molecular and cellular pathophysiology of heart failure","volume":"27","author":"Piano","year":"1998","journal-title":"Heart Lung"},{"issue":"10 Suppl","key":"10.1016\/j.xphs.2022.01.001_bib0013","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1097\/00003246-199310001-00006","article-title":"Role of tumor necrosis factor-alpha in disease states and inflammation","volume":"21","author":"Strieter","year":"1993","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.xphs.2022.01.001_bib0014","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.rdc.2010.02.002","article-title":"Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment","volume":"36","author":"Kaplan","year":"2010","journal-title":"Rheum Dis Clin"},{"issue":"6","key":"10.1016\/j.xphs.2022.01.001_bib0015","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-\u03baB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.xphs.2022.01.001_bib0016","first-page":"9","article-title":"TNF-\u03b1 in the cardiovascular system: from physiology to therapy","volume":"7","author":"Urschel","year":"2015","journal-title":"Internat J Interferon Cytokine Med Res"},{"issue":"1","key":"10.1016\/j.xphs.2022.01.001_bib0017","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clim.2007.08.012","article-title":"TNF\u03b1 blockade in human diseases: an overview of efficacy and safety","volume":"126","author":"Lin","year":"2008","journal-title":"Clin Immunol"},{"issue":"9","key":"10.1016\/j.xphs.2022.01.001_bib0018","first-page":"512","article-title":"The nanomedicine revolution: part 1: emerging concepts","volume":"37","author":"Ventola","year":"2012","journal-title":"Pharm Therap"},{"issue":"3","key":"10.1016\/j.xphs.2022.01.001_bib0019","first-page":"161","article-title":"Preparation, characterization and anti-inflammatory activity of chitosan stabilized silver nanoparticles","volume":"5","author":"Prasad","year":"2013","journal-title":"Res J Pharm Dosage Forms Technol"},{"issue":"2","key":"10.1016\/j.xphs.2022.01.001_bib0020","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/toxsci\/kfu202","article-title":"In vivo and in vitro toxicity and anti-inflammatory properties of gold nanoparticle bioconjugates to the vascular system","volume":"142","author":"Uchiyama","year":"2014","journal-title":"Toxicol Sci"},{"issue":"93","key":"10.1016\/j.xphs.2022.01.001_bib0021","doi-asserted-by":"crossref","first-page":"51459","DOI":"10.1039\/C4RA10003D","article-title":"One-step biofabrication of copper nanoparticles from Aegle marmelos correa aqueous leaf extract and evaluation of its anti-inflammatory and mosquito larvicidal efficacy","volume":"4","author":"Angajala","year":"2014","journal-title":"RSC Adv"},{"issue":"1","key":"10.1016\/j.xphs.2022.01.001_bib0022","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12989-014-0038-4","article-title":"Topically applied ZnO nanoparticles suppress allergen induced skin inflammation but induce vigorous IgE production in the atopic dermatitis mouse model","volume":"11","author":"Ilves","year":"2014","journal-title":"Part Fibre Toxicol"},{"issue":"6","key":"10.1016\/j.xphs.2022.01.001_bib0023","first-page":"737","article-title":"Titanium dioxide nanoparticles prime a specific activation state of macrophages","volume":"11","author":"Huang","year":"2017","journal-title":"Nanotoxicology"},{"issue":"31","key":"10.1016\/j.xphs.2022.01.001_bib0024","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1016\/j.biomaterials.2009.07.065","article-title":"Antifungal activity of silver nanoparticles against Candida spp","volume":"30","author":"Pan\u00e1\u010dek","year":"2009","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.xphs.2022.01.001_bib0025","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/cmdc.200900049","article-title":"Further evidence of the anti-inflammatory effects of silver nanoparticles","volume":"4","author":"Wong","year":"2009","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.xphs.2022.01.001_bib0026","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.4238\/2015.April.17.15","article-title":"Effects of silver nanoparticles and gold nanoparticles on IL-2, IL-6, and TNF-\u03b1 production via MAPK pathway in leukemic cell lines","volume":"14","author":"Parnsamut","year":"2015","journal-title":"Genet Mol Res"},{"issue":"sup1","key":"10.1016\/j.xphs.2022.01.001_bib0027","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1080\/21691401.2018.1446968","article-title":"Nano-gold displayed anti-inflammatory property via NF-kB pathways by suppressing COX-2 activity","volume":"46","author":"Khan","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2022.01.001_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms11171","article-title":"GATA3 induces human T-cell commitment by restraining Notch activity and repressing NK-cell fate","volume":"7","author":"Van de Walle","year":"2016","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.001_bib0029","first-page":"392","article-title":"Synthesis and characterization of zinc oxide nanopartilce and its application on fabrics for microbe resistant defence clothing","volume":"3","author":"Parthasarathi","year":"2011","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.xphs.2022.01.001_bib0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4028\/www.scientific.net\/AMR.678.297","author":"Suresh","year":"2013","journal-title":"Adv Mater Res"},{"issue":"32","key":"10.1016\/j.xphs.2022.01.001_bib0031","doi-asserted-by":"crossref","first-page":"15700","DOI":"10.1021\/jp061667w","article-title":"Turkevich method for gold nanoparticle synthesis revisited","volume":"110","author":"Kimling","year":"2006","journal-title":"J Phys Chem B"},{"issue":"40","key":"10.1016\/j.xphs.2022.01.001_bib0032","doi-asserted-by":"crossref","DOI":"10.3791\/2017-v","article-title":"Human T lymphocyte isolation, culture and analysis of migration in vitro","author":"Lefort","year":"2010","journal-title":"J Vis Exp"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.001_bib0033","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s10616-014-9836-7","article-title":"Improving the methods for isolation of monocyte and establishing macrophage cell culture in caprine model","volume":"68","author":"Shaqinah","year":"2016","journal-title":"Cytotechnology"},{"key":"10.1016\/j.xphs.2022.01.001_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2021.01.012","article-title":"Laser responsive cisplatin-gold nano-assembly synergizes the effect of cisplatin with compliance","author":"Rehman","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2022.01.001_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IJN.S176868","article-title":"Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs","volume":"14","author":"Kanwal","year":"2019","journal-title":"Int J Nanomed"},{"issue":"10","key":"10.1016\/j.xphs.2022.01.001_bib0036","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1007\/s11033-020-05824-6","article-title":"Gene expression of thrombomodulin, TNF-\u03b1 and NF-KB in coronary artery disease patients of Pakistan","volume":"47","author":"Rafiq","year":"2020","journal-title":"Mol Biol Rep"},{"issue":"6","key":"10.1016\/j.xphs.2022.01.001_bib0037","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C T method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.001_bib0038","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.xphs.2022.01.001_bib0039","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/toxsci\/kfr149","article-title":"Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles","volume":"123","author":"Choi","year":"2011","journal-title":"Toxicol Sci"},{"issue":"6","key":"10.1016\/j.xphs.2022.01.001_bib0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.5001\/omj.2011.101","article-title":"Gastrointestinal and cardiovascular risk of nonsteroidal anti-inflammatory drugs","volume":"26","author":"Al-Saeed","year":"2011","journal-title":"Oman Med J"},{"issue":"20","key":"10.1016\/j.xphs.2022.01.001_bib0041","first-page":"2706","article-title":"Evaluation of analgesic and anti-inflammatory effect of nanoparticles of magnesium oxide in mice with and without ketamine","volume":"17","author":"Jahangiri","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.xphs.2022.01.001_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-8977-10-46","article-title":"Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells","volume":"10","author":"Wu","year":"2013","journal-title":"Part Fibre Toxicol"},{"key":"10.1016\/j.xphs.2022.01.001_bib0043","first-page":"4","article-title":"Hypoglycemic and anti-inflammatory effect of gold nanoparticles in streptozotocin-induced type 1 diabetes in experimental rats","volume":"3","author":"Edrees","year":"2017","journal-title":"Nanotechnology"},{"issue":"11","key":"10.1016\/j.xphs.2022.01.001_bib0044","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4103\/1735-1995.172811","article-title":"Biochemical and molecular evidences on the protection by magnesium oxide nanoparticles of chlorpyrifos-induced apoptosis in human lymphocytes","volume":"20","author":"Heydary","year":"2015","journal-title":"J Res Med Sci"},{"issue":"12","key":"10.1016\/j.xphs.2022.01.001_bib0045","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00204-011-0722-1","article-title":"Evaluation of the cytotoxic and inflammatory potential of differentially shaped zinc oxide nanoparticles","volume":"85","author":"Heng","year":"2011","journal-title":"Arch Toxicol"},{"issue":"20","key":"10.1016\/j.xphs.2022.01.001_bib0046","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.112.000116","article-title":"Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice","volume":"127","author":"Majmudar","year":"2013","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.xphs.2022.01.001_bib0047","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/biom9090416","article-title":"The therapeutic potential of nanoparticles to reduce inflammation in atherosclerosis","volume":"9","author":"Mahdavi Gorabi","year":"2019","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.xphs.2022.01.001_bib0048","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ihj.2017.02.007","article-title":"Nanomedicine in coronary artery disease","volume":"69","author":"Ambesh","year":"2017","journal-title":"Indian Heart J"},{"issue":"Supplement 2","key":"10.1016\/j.xphs.2022.01.001_bib0049","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2337\/diab.41.2.S97","article-title":"Role of cytokines in inducing hyperlipidemia","volume":"41","author":"Feingold","year":"1992","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.001_bib0050","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI113733","article-title":"Tumor necrosis factor and the acute metabolic response to tissue injury in man","volume":"82","author":"Starnes","year":"1988","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.001_bib0051","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","article-title":"The role of TNF-\u03b1 in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk","volume":"48","author":"Popa","year":"2007","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.xphs.2022.01.001_bib0052","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1084\/jem.163.3.740","article-title":"Modulation of endothelial cell hemostatic properties by tumor necrosis factor","volume":"163","author":"Nawroth","year":"1986","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.xphs.2022.01.001_bib0053","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0008-6363(99)00138-8","article-title":"Tumour necrosis factor alpha and the cardiovascular system: its role in cardiac allograft rejection and heart disease","volume":"43","author":"Azzawi","year":"1999","journal-title":"Cardiovasc Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492200003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492200003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:30Z","timestamp":1777420830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235492200003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S002235492200003X"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2022.01.001","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticles as a Novel Tool to Inhibit Inflammatory Cytokines in Human Lymphocytes and Macrophages of Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2022.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}